Plinabulin
Term · Oncology and biomedicine · MLC-T-ONC-016115
An orally active diketopiperazine derivative with potential antineoplastic activity. Plinabulin selectively targets and binds to the colchicine-binding site of tubulin, thereby interrupting equilibrium of microtubule dynamics. This disrupts mitotic spindle assembly leading to cell cycle arrest at M phase and blockage of cell division. In addition, plinabulin may also inhibit growth of proliferating vascular endothelial cells, thereby disrupting the function of tumor vasculature that further contributes to a decrease in tumor cell proliferation.
| Identifier | MLC-T-ONC-016115 |
|---|---|
| Field | Oncology and biomedicine |
| Synonyms | vascular-disrupting agent NPI-2358 |
| References | National Cancer Institute Thesaurus (CC BY 4.0) |
Record as JSON
{
"id": "MLC-T-ONC-016115",
"term": "Plinabulin",
"field": "Oncology and biomedicine",
"definition": "An orally active diketopiperazine derivative with potential antineoplastic activity. Plinabulin selectively targets and binds to the colchicine-binding site of tubulin, thereby interrupting equilibrium of microtubule dynamics. This disrupts mitotic spindle assembly leading to cell cycle arrest at M phase and blockage of cell division. In addition, plinabulin may also inhibit growth of proliferating vascular endothelial cells, thereby disrupting the function of tumor vasculature that further contributes to a decrease in tumor cell proliferation.",
"synonyms": [
"vascular-disrupting agent NPI-2358"
],
"references": [
"National Cancer Institute Thesaurus"
],
"url": "https://mlchart.com/terminology/oncology/plinabulin/"
}
Record 13,357 of 17,717 in Oncology and biomedicine terminology (MLC-0111). Request the full dataset.